American Century Companies’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91M	Buy	117,738 +13,444	+13%	+$238K	﹤0.01%	2135
2025 Q4	$1.95M	Buy	104,294 +8,563	+9%	+$142K	﹤0.01%	2094
2025 Q3	$1.4M	Buy	95,731 +4,230	+5%	+$53.5K	﹤0.01%	2189
2025 Q2	$1.01M	Buy	91,501 +5,794	+7%	+$56.3K	﹤0.01%	2290
2025 Q1	$765K	Buy	85,707 +7,776	+10%	+$72.4K	﹤0.01%	2348
2024 Q4	$733K	Buy	77,931 +8,289	+12%	+$75.4K	﹤0.01%	2364
2024 Q3	$561K	Buy	69,642 +12,031	+21%	+$104K	﹤0.01%	2437
2024 Q2	$489K	Buy	57,611 +6,026	+12%	+$54.4K	﹤0.01%	2451
2024 Q1	$463K	Buy	51,585 +8,708	+20%	+$80.7K	﹤0.01%	2473
2023 Q4	$482K	Buy	42,877 +6,754	+19%	+$68K	﹤0.01%	2371
2023 Q3	$312K	Buy	36,123 +4,641	+15%	+$44.8K	﹤0.01%	2450
2023 Q2	$326K	Buy	31,482 +10,278	+48%	+$113K	﹤0.01%	2367
2023 Q1	$228K	Buy	21,204 +8,506	+67%	+$89.9K	﹤0.01%	2381
2022 Q4	$142K	Buy	+12,698	New	+$133K	﹤0.01%	2397
2017 Q4	–	Sell	-28,279	Closed	-$968K	–	1361
2017 Q3	$968K	Buy	28,279 +198	+0.7%	+$6.47K	﹤0.01%	1148
2017 Q2	$1.12M	Sell	28,081 -2,672	-9%	-$103K	﹤0.01%	1122
2017 Q1	$1.13M	Buy	+30,753	New	+$982K	﹤0.01%	1120